Free Trial
ASX:PAL

Palla Pharma (PAL) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Palla Pharma

Palla Pharma Limited, a vertically integrated pharmaceutical company, produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway. It also produces and distributes poppy seeds to culinary markets. The company was formerly known as TPI Enterprises Limited and changed its name to Palla Pharma Limited in June 2019. Palla Pharma Limited was incorporated in 2004 and is headquartered in Melbourne, Australia.

PAL Stock News Headlines

See More Headlines
Receive PAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Palla Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Farm Products
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$16.74 million
Book Value
A$0.12 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Jarrod David Ritchie B.Sc.
    BSc (Hons), Advisor
  • Mr. Giles Moss
    Chief Exec. Officer
  • Mr. Paul A. Sherman B.Bus
    C.A., CA, M.B.A., MBA, Chief Financial Officer

This page (ASX:PAL) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners